←
NewLimit113 posts
NewLimit avatar

NewLimit

@newlimit

Radically extending human healthspan

◷ Joined October 2021▧ 5 Photos and videos
NewLimit avatar
NewLimit@newlimit·Jun 2

Following breakthrough results, we’re bringing longevity medicine to human trials. We’ve raised a $435M Series C led by @foundersfund to make it happen. Reprogramming cell age has the potential to create more healthy years for everyone. We're closer than ever to realizing it.

0:49
Blake Byers avatar
⟳ NewLimit retweeted
Blake Byers@byersblake·Oct 21

Over the summer, we achieved more drug development milestones than in the rest of @newlimit history. We scaled our manufacturing processes, ran our first large animal model studies, and engaged productively with regulators. Our pipeline of reprogramming payloads continued to grow, hitting new all time highs for both the quality of our best payloads and the quantity of payloads we explored. >2X stronger regenerative rescue in old hepatocytes +2 payloads rescue multiple functions in old hepatocytes +8 payloads restore function in old endothelial cells, +5 in hepatocytes 314X scale up of therapeutic manufacturing, 13X quality improvement 2.5X improvement in endothelial cell age prediction accuracy >5000 payloads tested (during just the summer) for effects on cell age (all time high!) 5X improvement in data efficiency from transfer learning

Jacob Kimmel avatar
⟳ NewLimit retweeted
Jacob Kimmel@jacobkimmel·Oct 21

summer @newlimit: we found our best age reprogramming payloads yet, hit more drug dev milestones than ever before, & welcomed new leaders to the team. it's the most exciting time in our history & we hope you consider joining us. highlights - >2X increase in regenerative restoration in old hepatocytes - +8 payloads restore endothelial function, +5 in hepatocytes - >300X scale up of therapeutic manufacturing, 13X quality improvement - 5X increase in sample efficiency for reprogramming AI

Post attachmentPost attachment
Brian Armstrong avatar
⟳ NewLimit retweeted
Brian Armstrong@brian_armstrong·Oct 16

All warfare is based on deception. I actually got first place on the healthmaxxing benchmark. Don't worry though Will, the other company I co-founded is developing drugs to rejuvenate your liver, so I got you.

Who would have thought that it took a 29-year-old Irishman to put the teetotalers of San Francisco in their place I have been training to competitively drink Guinness for decades I was born for this Sorry @elonmusk

Post attachment
Jacob Kimmel avatar
⟳ NewLimit retweeted
Jacob Kimmel@jacobkimmel·Sep 6

.@newlimit is hosting a dinner in boston on sept 24 to connect with talented scientists & engineers we promise an evening of surprising conversations, good food, & better company let us know if you or a friend are interested in joining! newlimit.notion.site/3cf10a8…

MTS avatar
⟳ NewLimit retweeted
MTS@MTSlive·Sep 1

NewLimit CEO @jacobkimmel explains the clinical trial bottleneck AI can't fix: biology has irreducible latency "It's unlikely we're gonna see rapid expedition of clinical trials because a lot of the periods of time can't be expedited based on the biological primitives. In computer science you often have a notion of bandwidth and latency." "There are some irreducible latencies in clinical trials. If you wanna give a drug to a patient and see if they're healthy a month later, it's not like you can enroll 30 patients and check back in one day. You just need to wait a full month. The classic nine people can't have a baby in one month story." "The other thing we can hope for is that the success rate might improve. Right now, rough math, roughly 9 out of 10 drugs that go into the clinic will ultimately fail." "If you're able to even just 2X that success rate, getting to 20% success rather than 10%, then you would double the number of drugs that come out every year, and you would cut the effective cost in half." @newlimit

1:25
The Techno Optimist avatar
⟳ NewLimit retweeted
The Techno Optimist@technooptimist1·Sep 1

.@newlimit CEO @jacobkimmel on why AI is biotech's biggest shift in 40+ years: "I really do think artificial intelligence in biopharma is the first revolution we've seen since recombinant DNA of the same scale. It's the first technology disruption on the same order of magnitude. And I think what we're going to see is some of these firms that are developing models that help us design molecules, partner with pharmas to develop those molecules and make medicines that just couldn't have existed before." — Jacob Kimmel, Co-Founder and CEO of NewLimit, on @corememory

2:43
Brian Armstrong avatar
⟳ NewLimit retweeted
Brian Armstrong@brian_armstrong·Jul 21

The two best longevity drugs on the market currently are exercise and sleep. And they're free! If @newlimit is successful, we might surpass those.

Jacob Kimmel avatar
⟳ NewLimit retweeted
Jacob Kimmel@jacobkimmel·Aug 18

first-in-history data arrived @newlimit today small piece of a note to our team. we are so lucky to be living in this future.

Post attachment
Jacob Kimmel avatar
⟳ NewLimit retweeted
Jacob Kimmel@jacobkimmel·Jul 13

enjoyed chatting with @SabrinaHalper in the lab (!) a few weeks back rarely do i get to cover whale lifespans, @newlimit, spacefaring human speciation events, & ai therapeutic design in one place

"Aging is the process of a complex system slowly falling into its chaotic disequilibrium. And it's not like evolution necessarily even set a lifespan for us. It is merely the result of, once the system has been established, how long its intrinsic property stayed ordered before it became disordered." I’m excited to share my conversation with @jacobkimmel of @newlimit. Every species who has ever lived has one shared certainty: we’ll age, decay, and die. Jacob and his team are among the small group of people on earth with the expertise and funding to work on this problem. We talked about why we age, whether cellular aging can actually be reversed, how evolution shaped our lifespan and our peaks, and how AI is fundamentally changing the next era of science. Recorded at New Limit’s HQ in South San Francisco. Timestamps: 00:00 Intro 01:25 Why Evolution Limits Lifespan 03:13 Evolution Tradeoffs Explained 07:44 Why Women Live Longer 10:15 Lessons from Long Lived Species 16:20 Peak Intelligence 23:26 What is Aging? 27:59 Yamanaka Factors 32:18 New Limit 33:56 AI's Role in Progress 37:28 Organ by Organ Longevity 40:28 Is Immortality Possible? 42:04 Lifespan Progress 45:44 How to Test Longevity Drugs 49:30 Placebo Mind Body Link 53:56 What longevity hacks actually work? 57:25 Peptides And Stem Cells 01:00:34 Gene Editing 01:05:10 Personalized Medicine 01:08:48 Philosophical Dilemmas of Longer Lifespans 01:14:57 Living Off Earth 01:16:55 AI And Bio Risks

1:23:37
Jacob Kimmel avatar
⟳ NewLimit retweeted
Jacob Kimmel@jacobkimmel·Jul 10

this is our most dynamic summer yet @newlimit - 3X data efficiency for reprogramming AI from lineage generalization - >100X manufacturing scale for our lead therapeutic asset - +4 leads that restore function in old hepatocytes, +5 payloads in endothelium & lots more in our blog

Post attachment
Brian Armstrong avatar
⟳ NewLimit retweeted
Brian Armstrong@brian_armstrong·Jun 10

NewLimit made major progress in the past year toward our mission of radically extending human healthspan. Check out this talk where we run through what we've built, and our vision for where it's going.

every year @newlimit, we host friends at the lab & share our progress for 2026, we announced: - 2X increase in discovery rates with AI systems - new program for endothelial cells - 0 -> 1 medicines headed to the clinic - accelerating recovery from alcohol some highlights --

5:25
Jacob Kimmel avatar
⟳ NewLimit retweeted
Jacob Kimmel@jacobkimmel·Jun 9

every year @newlimit, we host friends at the lab & share our progress for 2026, we announced: - 2X increase in discovery rates with AI systems - new program for endothelial cells - 0 -> 1 medicines headed to the clinic - accelerating recovery from alcohol some highlights --

5:25
Jacob Kimmel avatar
⟳ NewLimit retweeted
Jacob Kimmel@jacobkimmel·Jun 9

in our 2026 @newlimit progress update, we announced our first candidate medicine. it has the one of the most striking effects i’ve ever seen. a single treatment accelerates recovery from alcohol in old animals. it’s so dramatic you can see it with your bare eyes!

0:11
NewLimit avatar
NewLimit@newlimit·Jun 9

Each year, we share a public update on our progress @newlimit from our lab in South San Francisco. This year, we announced: 1. 2X increase in discovery rates with AI systems 2. New program focused on endothelial cells 3. 0 -> 1 medicines headed to the clinic Full event video below

51:56
Brian Armstrong avatar
⟳ NewLimit retweeted
Brian Armstrong@brian_armstrong·Jun 7

Imagine you had the energy, metabolism, and mental agility of your younger self - without the aches and pains that come from aging. That’s what we’re attempting to build at @NewLimit and it will be one of the most important achievements in human history ever if it works. We're on the cusp of this being tractable given the rise of AI to test more hypotheses in-silico, along with the rapidly falling cost of single cell sequencing, etc. We announced our Series C and upcoming human clinical trials this week, so still a long, long way to go, with many risks. But with hard work we've got a shot at making this a reality.

0:55